NorWest Mobile Diabetes and Kidney Screening and Intervention Project. Cindy Peters Primary Care Nurse

Similar documents
Key Elements in Managing Diabetes

Chronic Kidney Disease due to Diabetes (Diabetic Nephropathy)

CKD and risk management : NICE guideline

QUICK REFERENCE FOR HEALTHCARE PROVIDERS

CHI Franciscan. Matt Levi Director Virtual Health Services. March 31, 2015

CKDinform: A PCP s Guide to CKD Detection and Delaying Progression

ADVANCE post trial ObservatioNal Study

2016 Community Service Plan & Community Health Improvement Plan

SERVICE SPECIFICATION 6 Conservative Management & End of Life Care

Nephrology referral - Does my patient need it? Disclosure

Descriptive Epidemiology of STBBIs in the Winnipeg Health Region

Diabetes and Kidney Disease. Kris Bentley Renal Nurse practitioner 2018

Diabetes Management: Interventions Engaging Community Health Workers

Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC

1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria

HUDSON HEADWATERS HEALTH NETWORK THE ROAD TO DIABETES RECOGNITION

Professor Suetonia Palmer

A n aly tical m e t h o d s

KEEP 2.0 Annual Data Report Chapter Five

year in review 2015/2016 manitoba renal program Winnipeg Regional Health Authority manitoba renal program

Composite Performance Report

Quality ID #236 (NQF 0018): Controlling High Blood Pressure National Quality Strategy Domain: Effective Clinical Care

The future is here. It s just not widely distributed yet. William Gibson

Chronic Disease Management Living Well with a Chronic Condition

The Health Problem: Guidelines: NHS Priority:

Online clinical pathway for chronic kidney disease (CKD) in primary care. February 27, 2015 Dr. Kerry McBrien University of Calgary

Interventions to reduce progression of CKD what is the evidence? John Feehally

Supplementary Online Content

Integrating Medical and Social Support for Elderly System & Technology Enabled Service Innovations. Dr Christina MAW Hospital Authority, Hong Kong

Hypertension diagnosis (see detail document) Diabetic. Target less than 130/80mmHg

Chapter 2: Identification and Care of Patients With CKD

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu

UNIVERSITY OF CALGARY. diabetes mellitus. Vinay Deved A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES

Diabetes and Hypertension

Chapter Two Renal function measures in the adolescent NHANES population

Blood Pressure Acre Surgery Diviash Thakrar

Office Management of Reduced GFR Practical advice for the management of CKD

Chapter 1: CKD in the General Population

2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

The Hypertension Clinic is a part of the Internal Medicine

Swindon Diabetes Guidelines: Management of Chronic Kidney Disease Associated with Diabetes Mellitus

Systolic Blood Pressure Intervention Trial (SPRINT)

Is Knowing Half the Battle? Behavioral Responses to Risk Information from the National Health Screening Program in Korea

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

USRDS UNITED STATES RENAL DATA SYSTEM

Section 1: 1: Trends. Section 2: 2: Comparisons to to Overall Portland Area Area Results for for

egfr > 50 (n = 13,916)

Department of Nephrology

Chronic Kidney Disease: Optimal and Coordinated Management

Vascular checks a vascular risk assessment and management. Heather White Deputy Branch Head Vascular Programme

CKD Prevention Program Protocol

National Audit of CKD in Primary Care

Manitoba Cervical Cancer Screening Program. Operations & Statistical Report and 2006

CKD at the primary and secondary care interface. Paul Cockwell Consultant Nephrologist Clinical Service Lead Renal Medicine, QEHB

Medication Therapy Management Solution

Standards of Medical Care in Diabetes 2016

A NEW FOOD AND HEALTH PARTNERSHIP: COMMUNITY FOOD CENTRES CANADA AND NORWEST COOP COMMUNITY FOOD CENTRE

Addressing Chronic Kidney Disease in People with Multiple Chronic Conditions

May 2016 CTC/OHIC Measure Specifications

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

Chronic kidney disease (CKD) has received

Patient engagement and empowerment: Strategies to improve the chronic disease control among Ethnical Minority Patients in the primary care


The Role of the Diabetes Educator within the Patient-Centered Medical Home & Future Roles

CKD & HT. Anne-Marie Angus

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

Quality ID #122: Adult Kidney Disease: Blood Pressure Management National Quality Strategy Domain: Effective Clinical Care

BASELINE CHARACTERISTICS OF THE STUDY POPULATION

Location of initiative York Region Chronic Kidney Disease Program, Mackenzie Richmond Hill Hospital, Richmond Hill, ON

Nephrology. 3 rd Year Revision Session 06/05/17 Cathal Hannan

Preventive Cardiology

Playing the Game: Strategies For Completing the ACO Measures

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD?

Quality ID #119 (NQF 0062): Diabetes: Medical Attention for Nephropathy National Quality Strategy Domain: Effective Clinical Care

When should you treat blood pressure in the young?

Chronic kidney disease screening and assessment

Stages of Chronic Kidney Disease (CKD)

Outline. Outline 10/14/2014 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

Diabetes and Quality Measures.

PRIMARY PHASE 2 ANALYSES FROM CARDINAL: A PHASE 2/3 STUDY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME

Cardiovascular Disease Risk Prediction in Indigenous Australians

HEDIS QUICK REFERENCE GUIDE: DOCUMENTATION TIPS FOR ADULT MEASURES

Guest Speaker Evaluations Viewer Call-In Thanks to our Sponsors: Phone: Fax: Public Health Live T 2 B 2

Faculty of Health Sciences Outcomes of campaigns for Palestine refugees with diabetes mellitus attending UNRWA health centers

Management of early chronic kidney disease

Reframe the Paradigm of Hypertension treatment Focus on Diabetes

KEEP Summary Figures S40. Am J Kidney Dis. 2012;59(3)(suppl 2):S40-S64

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

Five Years Outcome Review of IPCP Program for Newly Diagnosed Type II Diabetes (Family Medicine Diabetes Triage Clinic) in NTWC

Summary of Recommendation Statements Kidney International Supplements (2013) 3, 5 14; doi: /kisup

KEEP Summary Figures S32. Am J Kidney Dis. 2011;57(3)(suppl 2):S32-S56

Diabetes Education and Outreach with the WVU Extension Service

HANS KAI: A community-led program that empowers people to take control of their own health

Public Health Unit Tobacco Use Cessation Services

2017 Diabetes. Program Evaluation. Our mission is to improve the health and quality of life of our members

Michigan s Diabetes Prevention and Control Program & National Kidney Foundation Michigan: A Successful Partnership

Repeat ischaemic heart disease audit of primary care patients ( ): Comparisons by age, sex and ethnic group

The Pursuit of Prevention of Renal failure in an imperfect world-is it possible in the 21 st century?

>4000 mg/dl (=20000/(500/100)) >615 mmol/l (=20000/(65*0.5))

Transcription:

NorWest Mobile Diabetes and Kidney Screening and Intervention Project Cindy Peters Primary Care Nurse

Interprofessional and Intersectoral partnerships

Aims of FINISHED (First Nations Community Based Screening to Improve Kidney Health and Prevent Dialysis) Partnership between the Diabetes Integration Project and Manitoba Renal Program Goal: To improve the health of First Nations communities though screening and treatment of kidney disease to prevent kidney failure requiring dialysis. 1. Screen for kidney disease in high risk, underserviced communities Instant, direct feedback to clients on level of risk 2. Refer clients at risk to appropriate treatments 3. Enter risk scores and information into the electronic Kidney Health record. 4. Use project results to convince MB Health and Health Canada that screening should be permanently funded

Aims of NorWest Project Through screen/triage/treat clinics identify: Individuals at risk for developing diabetes, hypertension or kidney disease Individuals with diabetes who may not have been screened for complications 5 year kidney failure risk prediction To provide follow up to those with risk factors (connect to primary care/chronic disease team, primary care provider, specialty care, other supports)

Key Partners

Rapid testing = 6-12 min Point of Care Testing & Instant Risk Prediction Finger prick for blood and small urine sample egfr, Ca, PO4, T-CO2, Albumin, Urine ACR, HgbA1C Real time tablet-based data entry custom app for this project Equipment undergoes quality assurance process each day to ensure precision and accuracy Mobile Chemistry Analyzer A1C/ACR Analyzer

Rationale MB has among the highest rate of kidney failure in all of Canada Screening general population is not recommended Focus on hard to reach high risk population groups (targeted screening) Prevent dialysis (determine 5 year risk prediction) Increase access to supports (primary health care)

At the screen/triage/treat clinics we will Obtain informed consent, complete health questionnaire Measure blood pressure (6 readings) Finger prick blood sample Urine sample Results are available within about 15 minutes (usually will spend about 30 45 minutes to complete entire process) Education provided based on results Classified according to kidney disease risk level (4 categories of risk) Letters sent to primary care provider if applicable (if blood sugar or blood pressure elevated or kidney risk score indicates requires follow up Referral made to nephrology(kidney specialist)depending on risk level

Screening Blood Pressure egfr, Ca, PO4, HCO3, albumin Urine ACR HbA1c Risk Prediction No Current Risk BP <160/90 egfr > 60 ACR = < 3.0 HgA1c <7% and No known DM Low Risk egfr <60 and 1-3% risk of kidney failure over 5 yr OR BP>160/90 OR HgA1c>7% OR 3.0 > ACR > 100 Intermediate Risk 3-10%risk of kidney failure over 5 yr OR 100 < ACR < 200 High Risk >10%/ 5 yr risk of kidney failure OR ACR > 200 Treatment Lifestyle counseling Diet and Exercise Treatment Lifestyle counseling Diet and exercise Letter to primary care practitioner Flag for yearly rescreening Treatment Lifestyle counseling Diet and exercise Arrange referral to MRP for evaluation by a nephrologist Treatment Lifestyle counseling Arrange urgent referral to the MRP for detailed evaluation by a nephrologist & team

Consent

Consent

Consent

Point of Care Testing blood pressure

Point of Care Testing blood and urine

Point of Care Testing

Education

Findings May 2015 July 2016 (total of 103 screening days) 430 community members screened: 219 First Nations, Inuit or Metis 65 Filipino 44 South Asian 102 Other ethnicities No risk 284 Low risk 137 Intermediate risk 5 High risk 3 81 referrals to attach to primary care provider 74 referrals to diabetes education 108 referrals to registered dietitian (194 for group education) 34 referrals for smoking cessation 67 referrals to foot care education 14 referrals to counseling supports

Demographic Characteristics of Screening Cohort Findings First Nations South Asian (n = 219) (n = 44) Filipino (n = 65) Other (n = 102) Age (years) 41 (13.6) 43.2 (15.6) 54.1 (13.8) 55.5 (15.9) Sex (% female) 64.8% 65.9% 53.9% 72.6% HgbA1C (% 6.5%) 14.2% 4.7% 24.6% 22.8% egfr (ml/min per 1.73 m 2 ) 114.5 (42.6) 141.9 (60.7) 98.3 (40.9) 102.6 (37.2) egfr (ml/min per 1.73 m 2 ) (% < 60) Urine ACR (mg/mmol) 3.2% 2.3% 12.3% 6.9% 1.8 (0.7-1.9) 1.9 (0.9-1.9) 1.9 (1.7-2.2) 1.9 (0.8-2.1) Albuminuria (% 3 mg/mmol) 14.2% 4.7% 20.0% 18.6% Chronic Kidney Disease (egfr < 60 or Urine ACR > 16.0% 6.8% 24.6% 21.6% 3 mg/mmol) Elevated Blood Pressure ( 140 mmhg SBP or 90 mmhg DBP) Systolic BP (mmhg) 17.4% 120.1 (14.2) 13.6% 119.2 (16.8) 23.1% 125.2 (19.1) 25.5% 125.8 (21.6) Diastolic BP (mmhg) 78.4 (10) 75 (8.4) 77.5 (10.8) 76.9 (13.4) Kidney Failure Risk (Item S1) No Risk 67.0% 86.1% 55.0% 64.3% Low Risk 31.7% 14.0% 38.3% 33.7% Int. Risk 0.9% 0.0% 1.7% 2.0% High Risk 0.5% 0.0% 5.0% 0.0% Summary statistics given as mean ± SD for normally distributed variables, median (interquartile range) for non-normally distributed variables, and percentages (N) for categorical variables. Some categories may not sum to 100% due to rounding. HgbA1C: Glycated Hemoglobin, SBP: Systolic Blood Pressure, DBP: Diastolic Blood Pressure. The criteria for determination of kidney failure risk are presented in Item S1.

Findings Further extrapolation of data from Manitoba Centre for Health Policy (MCHP) is underway Data analysis will be collated from a variety of databases including income, education, billing data, laboratory data as well as other social complexity measures Phase 2 focus on children, youth and families with risk factors

Training and Capacity Building 2 Project Leads 8 staff trained on operating procedures to run clinics Capacity Development Week provided by partners Collaboration of DIP and MRP training on use of POC equipment, operating procedures and community outreach Shadowing screening clinics in Rolling River First Nation, MB

Promotional pamphlets Community Engagement Strategy and Outreach Involvement of Community Development team, Indigenous outreach worker, Immigrant Settlement Program Presented at networks and advisories Community leaders Food Banks / Resource Centres Leaflets to MB housing residences Promoting to those working in community (EIA) WRHA Diabetes Network partners

Thank you to our Partners!

Thank you! www.norwestcoop.ca Join Us